4-phenylbutyric acid has been researched along with Anterior Ischemic Optic Neuropathy in 1 studies
4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.
Excerpt | Relevance | Reference |
---|---|---|
" In this study, we investigated the expression of key molecules in the ER stress pathways following nonarteritic anterior ischemic optic neuropathy (AION), the most common acute optic neuropathy in adults over 50, and assessed the impact of chemical chaperon 4-phenylbutyric acid (4-PBA) in vivo." | 3.91 | Increased ER Stress After Experimental Ischemic Optic Neuropathy and Improved RGC and Oligodendrocyte Survival After Treatment With Chemical Chaperon. ( Heng, K; Hu, Y; Huang, H; Kumar, V; Liao, YJ; Mesentier-Louro, LA; Oh, AJ; Shariati, MA, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kumar, V | 1 |
Mesentier-Louro, LA | 1 |
Oh, AJ | 1 |
Heng, K | 1 |
Shariati, MA | 1 |
Huang, H | 1 |
Hu, Y | 1 |
Liao, YJ | 1 |
1 other study available for 4-phenylbutyric acid and Anterior Ischemic Optic Neuropathy
Article | Year |
---|---|
Increased ER Stress After Experimental Ischemic Optic Neuropathy and Improved RGC and Oligodendrocyte Survival After Treatment With Chemical Chaperon.
Topics: Animals; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; | 2019 |